Trials / Completed
CompletedNCT00584376
Pregabalin (Lyrica) for the Treatment of Essential Tremor
A Multi-site, Double-blind, Randomized, Placebo-controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of Essential Tremor
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- University of South Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This will be a multi-site, prospective, double-blind, randomized, placebo-controlled, crossover trial conducted over 6 months to assess the effectiveness and safety of PGB to treat symptoms of ET.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin | Gradually titrated dose ranging from 75mg po bid to 225mg po bid. |
| DRUG | Placebo | Placebo capsules which are identical in packaging, appearance and dosing as the active capsules. |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2008-01-02
- Last updated
- 2012-06-18
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00584376. Inclusion in this directory is not an endorsement.